Welcome to our dedicated page for Patterson Companies news (Ticker: PDCO), a resource for investors and traders seeking the latest updates and insights on Patterson Companies stock.
Patterson Companies, Inc. (Symbol: PDCO) is a leading specialty distributor in the dental and veterinary supply markets. The company is dedicated to addressing the needs of healthcare professionals by offering a comprehensive range of products and services. Patterson operates through two primary business segments: Patterson Dental and Patterson Animal Health, providing a 'total-package' approach for their customers.
Patterson Dental offers a virtually complete range of consumable dental products, advanced equipment, cutting-edge software, turnkey digital solutions, and value-added services. They cater to dentists and dental laboratories throughout North America, ensuring that professionals have access to the latest technology and supplies.
Patterson Animal Health, which includes Patterson Veterinary Supply and Animal Health International, is a major distributor of consumable supplies, equipment, software, diagnostic products, vaccines, and other pharmaceuticals. Their market extends to companion pets, production animals, and farm/fleet store markets across the United States, Canada, and the United Kingdom.
With a strong emphasis on continuous improvement and customer satisfaction, Patterson Companies has established strategic partnerships and invested in innovative solutions to stay ahead in these growing markets. The company's largest revenue segment is Animal Health, contributing significantly to its financial performance. Geographically, the majority of its revenue comes from the United States.
For the latest updates on Patterson Companies, including news on financial performance, product launches, and industry developments, visit their official website at www.pattersoncompanies.com.
Patterson Companies (PDCO) has announced a definitive agreement to be acquired by Patient Square Capital in a transaction valued at approximately $4.1 billion. Under the terms, shareholders will receive $31.35 in cash per share, representing a 49% premium to Patterson's 30-day volume-weighted average price ending December 4, 2024.
The transaction, unanimously approved by the Board of Directors (excluding CEO Don Zurbay), includes a 40-day 'go-shop' period allowing Patterson to solicit alternative acquisition proposals. The deal is expected to close in Q4 of Patterson's fiscal 2025, subject to shareholder and regulatory approvals. Upon completion, Patterson will become private and delist from NASDAQ while maintaining its St. Paul, Minnesota headquarters.
Rectangle Health announced integrations with Patterson Dental Supply, a subsidiary of Patterson Companies (Nasdaq: PDCO). The integration connects Rectangle Health's Practice Management Bridge® platform with Patterson's dental practice management software solutions - Dolphin Management, Fuse, and Eaglesoft.
The collaboration aims to enhance payment processing capabilities for dental practices through features including:
- Streamlined payment processing workflows
- Multiple payment options including mobile, online, and contactless
- Automated payment reminders and Text to Pay functionality
- Improved cash flow and Accounts Receivable collection rates
Patterson Companies (NASDAQ: PDCO) reported Q2 fiscal 2025 results with net sales increasing 1.3% to $1.67 billion. The company posted GAAP earnings of $0.30 per diluted share and adjusted earnings of $0.47 per diluted share, both impacted by the cybersecurity attack on Change Healthcare.
The Dental segment saw internal sales decrease 2.3%, while Animal Health segment internal sales grew 1.9%. The company revised its fiscal 2025 guidance, with GAAP earnings expected between $1.83-$1.93 per share and adjusted earnings between $2.25-$2.35 per share.
Patterson returned $96.2 million to shareholders through dividends and share repurchases in the first six months of fiscal 2025. The company also announced it is evaluating strategic alternatives, including potential sale or merger options.
Patterson Companies (PDCO) has scheduled its fiscal 2025 second-quarter conference call for Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company will release its earnings report before market opening on the same day. Investors can access the live webcast through the investor relations section of Patterson's website. An audio replay will be available for one week following the call, accessible through pre-registration with a unique access code.
Patterson Dental Supply has extended its strategic partnership with PDS Health through 2027, maintaining its position as the premier distributor for PDS Health's network of over 1,000 supported practices across the United States. The agreement covers merchandise, services, technology, and core equipment distribution. The relationship, spanning more than 25 years, began with Patterson as PDS Health's core technology provider and expanded in 2020 to include comprehensive distribution services. This extension reinforces their shared commitment to advancing patient-centered care and healthcare delivery innovation.
Patterson Companies has appointed Kristin Dietzler as Patterson Dental's North American president. Dietzler, who brings nearly 30 years of healthcare services experience, will report to Chief Operating Officer Kevin Pohlman and join the executive leadership team. She previously served as president of Carestream Health's Americas Region, where she achieved significant growth in sales and new products. Prior roles include positions at Medtronic and Covidien, where she managed large sales organizations and indirect channels.
Patterson Companies, Inc. (Nasdaq: PDCO) has announced two strategic acquisitions for its Animal Health business. In the UK, National Veterinary Services (NVS) will acquire Infusion Concepts , a leader in veterinary infusion and critical care products. This move aims to expand Patterson's portfolio with high-quality products for veterinary partners.
In the US, Animal Health International, Inc. will acquire the majority of Mountain Vet Supply's operating assets. This regional distributor, based in Fort Collins, Colorado, serves the production and companion animal market. The acquisition is expected to increase Patterson's presence in Colorado, Nebraska, Wyoming, and Montana markets, drive operating leverage, and create synergies with strategic vendors.
Both transactions are expected to close during Patterson's second fiscal quarter of FY2025. Financial terms were not disclosed.
Patterson Companies, Inc. (Nasdaq: PDCO) has announced a quarterly cash dividend of $0.26 per share. This decision was made by the company's Board of Directors on September 17, 2024. The dividend is scheduled to be paid on or around November 1, 2024, to shareholders who are on record as of the close of business on October 18, 2024. This regular quarterly dividend demonstrates Patterson Companies' commitment to providing consistent returns to its shareholders.
Patterson Companies (Nasdaq: PDCO) reported fiscal 2025 first quarter results with net sales decreasing 2.2% year-over-year to $1.54 billion. The company faced challenges due to the cybersecurity attack on Change Healthcare, impacting its dental segment's value-added services. GAAP earnings were $0.15 per diluted share, while adjusted earnings were $0.24 per diluted share. Despite these setbacks, Patterson reaffirmed its fiscal 2025 guidance, projecting GAAP earnings of $2.00 to $2.10 per diluted share and adjusted earnings of $2.33 to $2.43 per diluted share. The company returned $73.3 million to shareholders through dividends and share repurchases in Q1.
Patterson Dental has announced a new software integration with Bola AI, bringing voice-AI technology to dental practices using Fuse and Eaglesoft practice management software. This integration aims to increase clinical efficiency by streamlining documentation and charting tasks for hygienists.
Bola AI's Voice Perio system allows dental staff to record periodontal data directly into their practice management software in real-time. It offers high speech accuracy, filters out background noise, and supports flexible phrasing and various clinician accents.
Brad Joseph, VP of Product Management at Patterson Dental, emphasized the intuitive nature of the integration, while Rushi Ganmukhi, CEO of Bola AI, highlighted the shared goal of revolutionizing the dental environment through cutting-edge technology.
FAQ
What is the current stock price of Patterson Companies (PDCO)?
What is the market cap of Patterson Companies (PDCO)?
What does Patterson Companies, Inc. do?
What are the main segments of Patterson Companies?
Where does Patterson Companies generate most of its revenue?
Which segment contributes the most to Patterson's revenue?
What products does Patterson Dental offer?
What markets does Patterson Animal Health serve?
How does Patterson Companies stay competitive?
Where can I find the latest news about Patterson Companies?
Does Patterson Companies operate internationally?